NCT02882334

Brief Summary

Writer's cramp (WC) is a focal dystonia characterized by abnormal movements and postures during writing. Limited finger independence during writing manifests as difficulty suppressing unwanted activations of neighbouring non task-relevant fingers. WC patients also have difficulty in fine control of grip force. However, some previous studies indicate positive effects of individual finger movement training in WC although these studies lacked enhanced visual feedback of activations in 'stationary' fingers. The investigators have recently developed the Finger Force Manipulandum which quantifies the forces applied by the fingers in different tasks. This method is sensitive for detection and quantification of small unwanted contractions in non-active ('stationary') fingers. Forces in 'stationary' fingers can be displayed on-line providing enhanced feedback on independence of finger movements. The aim of this study is to test the effectiveness of finger individuation training using the FFM to improve symptoms in WC patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 24, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 29, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

November 8, 2016

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

July 19, 2021

Status Verified

July 1, 2021

Enrollment Period

4.1 years

First QC Date

August 24, 2016

Last Update Submit

July 16, 2021

Conditions

Keywords

Focal DystoniaWriter's cramp

Outcome Measures

Primary Outcomes (1)

  • change in writing speed after rehabilitation

    number of letters correctly copied in 60 seconds

    Change from baseline writing speed at week 8

Study Arms (2)

Finger individuation training

EXPERIMENTAL

Finger Force Manipulandum

Device: Finger Force Manipulandum

control

ACTIVE COMPARATOR

conventional physiotherapy

Other: Conventional physiotherapy

Interventions

Finger individuation training

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • writer's cramp (diagnostic confirmed by a neurologist specialized in movement disorders
  • handwriting speed \< 140 letters per minute
  • simple or complex writer's cramp
  • scholarship in French language
  • absence of treatment by botulinum neurotoxin, or last injection \> 3 months
  • age \> 18 and \< 71 years
  • informed consent
  • medical insurance coverage

You may not qualify if:

  • writer's cramp with no impact on writing
  • writing tremor
  • other neurological disease with effect on writing
  • pain or traumatism of the limb used for writing, requiring medical or surgical treatment in the last preceding months
  • participation in another research with a potential impact on evaluation criteria
  • pregnant or breast feeding patient
  • patient under judiciary protection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondation Ophtalmologique A. de Rothschild

Paris, 75019, France

Location

MeSH Terms

Conditions

Dystonic Disorders

Condition Hierarchy (Ancestors)

Movement DisordersCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Jean-Pierre BLETON, PhD

    Fondation OPH A de Rothschild

    STUDY CHAIR
  • Pavel Lindberg, PhD

    Centre de Psychiatrie et Neurosciences, Inserm U894

    STUDY DIRECTOR
  • Sophie SANGLA, MD

    Fondation OPH A de Rothschild

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 24, 2016

First Posted

August 29, 2016

Study Start

November 8, 2016

Primary Completion

December 1, 2020

Study Completion

December 1, 2020

Last Updated

July 19, 2021

Record last verified: 2021-07

Locations